{"id":"W2751912349","doi":"10.1016/j.ygyno.2017.08.022","title":"Antitumor activity and safety of the PARP inhibitor rucaparib in patients with high-grade ovarian carcinoma and a germline or somatic BRCA1 or BRCA2 mutation: Integrated analysis of data from Study 10 and ARIEL2","year":2017,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":278,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; Centre Hospitalier de l’Université de Montréal; University Health Network; Princess Margaret Cancer Centre","funders":"National Institute for Health and Care Research; Cancer Research UK; Clovis Oncology","keywords":"Medicine; Germline; Germline mutation; Somatic cell; PARP inhibitor; Poly ADP ribose polymerase; Ovarian carcinoma; Cancer research; Ovarian cancer; Mutation; Oncology; Polymerase; Internal medicine; Cancer; Genetics; Biology; DNA; Gene","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004956257,0.0003279033,0.0009656891,0.0005143738,0.0001072437,0.0006844104,0.0004291111,0.0003369557,0.0007004006],"category_scores_gemma":[0.002345934,0.0002285062,0.001038522,0.0006541163,0.0002770255,0.0004160709,0.0003871768,0.0006629937,0.0001091162],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005907822,"about_ca_system_score_gemma":0.0006081191,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005590445,"about_ca_topic_score_gemma":0.001709036,"domain_scores_codex":[0.9979334,0.001124795,0.0001549653,0.0002342337,0.0004428215,0.0001098032],"domain_scores_gemma":[0.9968883,0.0008955349,0.001474432,0.0002220239,0.0002650323,0.000254712],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.1229743,0.00256229,0.7722026,0.0008324978,0.008646002,0.0001761732,0.0002411082,0.002210442,0.01451207,0.00007354253,0.0005599206,0.07500912],"study_design_scores_gemma":[0.01378415,0.06731129,0.9018492,0.00007997258,0.005173713,0.0009349301,0.0001497228,0.002432366,0.005429294,0.00007619285,0.00274696,0.00003213768],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971012,0.001805258,0.0002155493,0.00003006303,0.000003630849,0.00007517159,0.0004182737,0.000007188095,0.0003436416],"genre_scores_gemma":[0.9979689,0.0003860727,0.0002634026,0.00005930563,0.00001488666,0.0000400455,0.001124153,0.000002520796,0.0001407219],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004956257,"threshold_uncertainty_score":0.0262115,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05371604839042909,"score_gpt":0.3439074718825645,"score_spread":0.2901914234921354,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}